Aledade and Humana have announced a 10-year collaboration to provide value-based primary care for Humana’s The two companies have been working together since 2019 in a limited number of markets, where they were able to increase primary care visits and bring impressive results, reducing inpatient hospitalizations by 5% and reducing readmissions by 12%, according to shared company data. By the end of 2022, more than 100,000 patients in Humana’s network received care under a value-based agreement with an Aledade-enabled physician practice.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on HUM:
- Humana price target lowered to $562 from $575 at Deutsche Bank
- Evolent Health price target raised to $45 from $40 at BTIG
- Humana to exit Employer Group Commercial Medical Products business
- Humana raises quarterly dividend 12.4% to 88.5c from 78.75c per share
- Humana and ChenMed announce five-year network agreement
